Cambridge Clinical Laboratories started its journey as Lab 21 in 2005. The objective for the company was to be a lab for the 21st century – a lab that would be an early adopter of new technologies for diagnostics. To offer personalised medicine and introduce new novel technologies and assays to help UK healthcare. This is still very much the aim today.

Core to the company’s stability is our people – many who have been around since the beginning. We are led by CEO Tony Cooke, a founding member. 

2020 threw a huge curveball for the world in the form of the Covid-19 pandemic. We reacted quickly and supported the UK’s efforts with care home, hotspot and private testing. Moving forward we plan to return to our roots; concentrating on how we can support the NHS to recover, looking at what new technologies we can introduce to the UK market, and how we can help individuals take personal responsibility for their health.